Literature DB >> 6745127

Aspirin in the prevention of myocardial infarction. Current status.

P C Elwood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745127     DOI: 10.2165/00003495-198428010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  22 in total

Review 1.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

2.  Platelet aggregates and mural microthrombi in the early stages of acute, fatal coronary disease.

Authors:  J W Haerem
Journal:  Thromb Res       Date:  1974-08       Impact factor: 3.944

3.  A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.

Authors:  P C Elwood; W O Williams
Journal:  J R Coll Gen Pract       Date:  1979-07

4.  Platelet function studies in human beings receiving 300 mg. of aspirin per day.

Authors:  R K Stuart
Journal:  J Lab Clin Med       Date:  1970-03

5.  Aspirin after myocardial infarction.

Authors: 
Journal:  Lancet       Date:  1980-05-31       Impact factor: 79.321

Review 6.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

7.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

8.  Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.

Authors:  C B Moschos; K Lahiri; M Lyons; A B Weisse; H A Oldewurtel; T J Regan
Journal:  Am Heart J       Date:  1973-07       Impact factor: 4.749

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion.

Authors:  C B Moschos; B Haider; C De La Cruz; M M Lyons; T J Regan
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

View more
  1 in total

1.  Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.